Location History:
- Quebec, CA (2014)
- L'Ancienne-Lorette, CA (2003 - 2021)
Company Filing History:
Years Active: 2003-2021
Title: The Innovative Contributions of Donald Poirier
Introduction
Donald Poirier is a notable inventor based in L'Ancienne-Lorette, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of aminosteroid derivatives and inhibitors for various steroid dehydrogenases. With a total of five patents to his name, Poirier's work has the potential to impact cancer treatment and other medical applications.
Latest Patents
Poirier's latest patents include the development of aminosteroid derivatives, which are described as estrane-based and androstane-based compounds. These compounds, specifically the piperazinyl-steroid compounds of Formula I, II, III, and IV, exhibit cytotoxicity against a variety of cancer cell lines. Additionally, he has patented inhibitors of 17β-hydroxysteroid dehydrogenases (17β-HSD) types 1, 3, and 10. These inhibitors are crucial for the treatment of cancer and other health conditions, with specific derivatives designed to target these enzymes effectively.
Career Highlights
Throughout his career, Donald Poirier has worked with esteemed institutions such as Université Laval and Endorecherche, Inc. His research has focused on the synthesis and application of steroid derivatives, contributing to advancements in pharmaceutical formulations. His innovative approach has garnered attention in the scientific community.
Collaborations
Poirier has collaborated with notable colleagues, including René Maltais and Jenny Roy. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality and impact of his research.
Conclusion
Donald Poirier's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in cancer treatment and pharmaceutical development.